FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory ...
Q3 2025 Earnings Call Transcript October 24, 2025 NatWest Group plc beats earnings expectations. Reported EPS is $0.53, ...
This first part of a two-part series explains how eFuses enable smarter protection against common short conditions in ...
Medpage Today on MSN
Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial
ATLANTA -- Oral tebipenem pivoxil (TBP-PI) was non-inferior to IV imipenem-cilastatin (IMI-CIL) for treating complicated ...
Q3 2025 Earnings Call Transcript October 24, 2025 General Dynamics Corporation beats earnings expectations. Reported EPS is ...
Researchers found that EnMax tablets safely and effectively reduce postoperative pain, inflammation (VRS), and biomarkers (CRP, ESR) in orthopedic surgery patients.
Defaqto has launched MPS Comparator performance averages for passive and active portfolios. The two new performance average ...
Jersey are closing in on appointing a new director of cricket for the island's national sides. Paul Hutchison stepped down ...
Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder ...
NatWest Group plc ( NYSE: NWG) Q3 2025 Earnings Call October 24, 2025 4:00 AM EDT Good morning, and welcome to the NatWest ...
The NIAGARA trial showed that adding durvalumab to neoadjuvant chemotherapy in MIBC patients did not negatively impact HRQOL outcomes. Significant improvement in event-free survival was observed with ...
A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback